Raj is a PhD with more than 15 years of experience in cancer research. He graduated with an MSc from the University of Toronto where he investigated signaling cascades implicated in human cancers and cancer stem cells. He obtained his PhD from the Swiss Federal Institute of Technology, Lausanne (EPFL).
While working at the Swiss Institute for Experimental Cancer Research-EPFL, he established a drug discovery platform to discover and develop novel anti-cancer therapeutics. During his undergraduate and graduate studies he was the recipient of numerous academic awards including the Canadian Genetic Disease Network scholarship, the American Association for Cancer Research-Scholar in Training award, a University of Toronto fellowship, the Frank Fletcher Memorial scholarship for cancer research and the Al and Hannah Peryl Graduate student scholarship.
Based on his drug discovery research, he was awarded an INNOGRANT and ENABLE grant by the Vice Presidency for Innovation and Technology Transfer at EPFL.
“My scientific research of the past decade, making a difference for cancer patients, is the ultimate reward in and of itself. This is what keeps me going.”
He was also selected to the Swiss National team of Venture Leaders. In 2014, Raj co-founded Cellestia Biotech AG and serves as Chief Scientific Officer and is on the Board of Directors.